首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1578273

全球動物藥物復配市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Animal Drug Compounding Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年09月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到2032年，全球動物藥物復配市場的市場規模將從2023年的19.8億美元達到近42.1億美元，2024-2032年研究期間的複合年成長率為8.73%。

動物藥物配製是鞏固、混合或修改混合物以根據單一動物或一小群動物的需要定製藥物的過程。通常由藥劑師或獸醫製作。動物藥物配製不需要 FDA 批准來證明安全性和有效性，除非配製原料或活性成分是 FDA 批准的藥物。用壓碎的片劑製備口服糊劑或懸浮液、混合兩種注射藥物或在藥物中添加調味劑是動物藥物配製的典型例子。

市場動態

已開發國家和發展中國家動物疾病負擔的增加、寵物人性化的增加以及動物收養的增加可能會推動全球動物藥物複合市場的發展。品牌處方藥的成本不斷增加、藥品的可及性不足以及網路上醫療資訊的不斷湧入是促進市場成長的其他因素。主要市場參與者致力於透過提供替代獸醫複合解決方案來擴大其產品組合，以滿足動物的所需需求。主要公司也與諮詢獸醫合作，提供有關常見化合物的最新資訊。然而，對安全性、品質和有效性的擔憂以及缺乏訓練有素的熟練醫療專業人員是限制動物藥物複合需求的因素。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球動物藥物複合市場的每個細分市場進行了包容性評估。動物藥物配製產業的成長和趨勢為本研究提供了整體方法。

市場區隔

動物藥物複合市場報告的這一部分提供了國家和區域層面的細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

依動物類型

伴侶動物（狗、貓等）
畜牧動物

按產品分類

抗感染劑
抗發炎劑
荷爾蒙及替代品
中樞神經系統藥劑
其他

依給藥途徑

口服
可注射
專題
其他

依劑型分類

暫停
解決方案
膠囊

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲動物藥物複合市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。動物藥物配製市場的主要參與者包括 Wedgewood Pharmacy、Vimian、Pharmaca.、Akina Animal Health、Triangle Blending.、DavisIslands Pharmacy And Blending Lab、Custom Med Complexing Pharmacy、Central Complexing Center South.、Wellness Pharmacy Of Cary.、米勒藥房。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按動物類型分類的市場吸引力分析
- 按產品分類的市場吸引力分析
- 按給藥途徑進行的市場吸引力分析
- 按劑型分類的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球動物藥物複方市場分析：依動物類型

依動物類型概述
按動物類型的歷史和預測數據分析
伴侶動物（狗、貓等）
畜牧動物

第 6 章：全球動物藥物複方市場分析：依產品分類

概述（按產品）
按產品分類的歷史和預測資料分析
抗感染劑
抗發炎劑
荷爾蒙及替代品
中樞神經系統藥劑
其他

第 7 章：全球動物藥物複方市場分析：依給藥途徑

依給藥途徑概述
按給藥途徑進行歷史和預測資料分析
口服
可注射
專題
其他

第 8 章：全球動物藥物複方市場分析：按劑型

按劑型概述
按劑型進行歷史和預測數據分析
暫停
解決方案
膠囊

第 9 章：全球動物藥物複方市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：動物藥複方公司的競爭格局

獸藥復配市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
Wedgewood Pharmacy

公司概況
公司收入
產品
最新動態

Vimian

公司概況
公司收入
產品
最新動態

Pharmaca.

公司概況
公司收入
產品
最新動態

Akina Animal Health

公司概況
公司收入
產品
最新動態

Triangle Compounding.

公司概況
公司收入
產品
最新動態

Davis Islands Pharmacy And Compounding Lab

公司概況
公司收入
產品
最新動態

Custom Med Compounding Pharmacy

公司概況
公司收入
產品
最新動態

Central Compounding Center South.

公司概況
公司收入
產品
最新動態

Wellness Pharmacy Of Cary.

公司概況
公司收入
產品
最新動態

Miller'S Pharmacy

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11215051

The global demand for Animal Drug Compounding Market is presumed to reach the market size of nearly USD 4.21 Billion by 2032 from USD 1.98 Billion in 2023 with a CAGR of 8.73% under the study period 2024-2032.

Animal drug compounding is the process of consolidating, blending or modifying mixtures to make a medication customized to the needs of an individual animal or a small group of animals. Pharmacists or veterinarians typically make them. Animal drug compounding does not require FDA approval to demonstrate safety and efficiency unless compounding raw material or active ingredient is an FDA-approved drug. Preparing an oral paste or suspension from crushed tablets, mixing two injectable medications, or adding flavoring to a drug are typical examples of animal drug compounding.

MARKET DYNAMICS

Spurring animal disease burden, increased humanization of pets, and rising adoption of animals in developed and developing nations are likely to boost the global animal drug compounding market. The increasing cost of branded prescription equivalents, inadequate accessibility to drugs, and the growing influx of medical information over the internet are other factors augmenting the market growth. Key market players are focused on expanding their portfolios by delivering substitute vet compounding solutions to meet the desired needs of animals. Key companies are also consolidating with consulting veterinarians to provide up-to-date information about common compounds. However, concerns about safety, quality, and effectiveness and the absence or lack of trained and skilled medical professionals are factors restraining demand for animal drug compounding.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Animal Drug Compounding. The growth and trends of Animal Drug Compounding industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Animal Drug Compounding market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Animal Type

Companion Animals (Dogs, Cats, Others)
Livestock Animals

By Product

Anti-Infective Agents
Anti-Inflammatory Agents
Hormones & Substitutes
CNS Agents
Others

By Route of Administration

Oral
Injectable
Topical
Others

By Dosage Form

Suspensions
Solutions
Capsules

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Animal Drug Compounding market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Animal Drug Compounding market include Wedgewood Pharmacy, Vimian, Pharmaca., Akina Animal Health, Triangle Compounding., Davis Islands Pharmacy And Compounding Lab, Custom Med Compounding Pharmacy, Central Compounding Center South., Wellness Pharmacy Of Cary., Miller'S Pharmacy. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ANIMAL DRUG COMPOUNDING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Animal Type
- 3.7.2 Market Attractiveness Analysis By Product
- 3.7.3 Market Attractiveness Analysis By Route of Administration
- 3.7.4 Market Attractiveness Analysis By Dosage Form
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ANIMAL DRUG COMPOUNDING MARKET ANALYSIS BY ANIMAL TYPE

5.1. Overview By Animal Type
5.2. Historical and Forecast Data Analysis By Animal Type
5.3. Companion Animals (Dogs, Cats, Others) Historic and Forecast Sales By Regions
5.4. Livestock Animals Historic and Forecast Sales By Regions

6. GLOBAL ANIMAL DRUG COMPOUNDING MARKET ANALYSIS BY PRODUCT

6.1. Overview By Product
6.2. Historical and Forecast Data Analysis By Product
6.3. Anti-Infective Agents Historic and Forecast Sales By Regions
6.4. Anti-Inflammatory Agents Historic and Forecast Sales By Regions
6.5. Hormones & Substitutes Historic and Forecast Sales By Regions
6.6. CNS Agents Historic and Forecast Sales By Regions
6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL ANIMAL DRUG COMPOUNDING MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

7.1. Overview By Route of Administration
7.2. Historical and Forecast Data Analysis By Route of Administration
7.3. Oral Historic and Forecast Sales By Regions
7.4. Injectable Historic and Forecast Sales By Regions
7.5. Topical Historic and Forecast Sales By Regions
7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL ANIMAL DRUG COMPOUNDING MARKET ANALYSIS BY DOSAGE FORM

8.1. Overview By Dosage Form
8.2. Historical and Forecast Data Analysis By Dosage Form
8.3. Suspensions Historic and Forecast Sales By Regions
8.4. Solutions Historic and Forecast Sales By Regions
8.5. Capsules Historic and Forecast Sales By Regions

9. GLOBAL ANIMAL DRUG COMPOUNDING MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ANIMAL DRUG COMPOUNDING COMPANIES

10.1. Animal Drug Compounding Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF ANIMAL DRUG COMPOUNDING INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Wedgewood Pharmacy
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Vimian
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Pharmaca.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Akina Animal Health
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Triangle Compounding.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Davis Islands Pharmacy And Compounding Lab
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Custom Med Compounding Pharmacy
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Central Compounding Center South.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Wellness Pharmacy Of Cary.
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Miller'S Pharmacy
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments